Denali Therapeutics Inc
(NAS:DNLI)
$
25.69
+1.37 (+5.63%)
Market Cap: 4.11 Bil
Enterprise Value: 3.43 Bil
PE Ratio: 0
PB Ratio: 4.91
GF Score: 33/100 Recent Filings
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Financials
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Ownership
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Material News Releases
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Proxy
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Others
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||